Presentation ACC 2012 Biodegradable Polymer Drug-Eluting Stents Versus Durable Polymer Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention Presenter: Robert A. Byrne March 24, 2012
News Conference News ACC 2012 Anti-inflammatory Lowers In-Stent Late Loss After BMS Implantation March 24, 2012
Presentation ACC 2012 Adjunctive Cilostazol Versus Double Dose Clopidogrel After PCI with Drug Eluting Stent: The HOST-ASSURE Randomized Trial Presenter: Hyo-Soo Kim March 24, 2012
News Conference News ACC 2012 ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months March 24, 2012
News Conference News TEST - COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip Shelley Wood April 10, 2001
Video » Interview ACC 2022: VALOR-HCM - Mavacamten As An Alternative To Surgical Septal Myectomy Or Alcohol Ablation In Patients With Severely Symptomatic Obstructive Hypertrophic Cardiomyopathy April 3, 2022